CVS 90.10 CVS Corp $CVS Hit a 52 week high of 90.26 Closing

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
CVS 90.10 CVS Corp $CVS Hit a 52 week high of 90.26 Closing the day 09:45 at 90.10 -0.02 -0.02% With a day low of 89.92 and a total volume of 226,723.

CVS Recent Posts: http://investorshangout.com/CVS-Health-Corp-CVS-50666/

CVS CVS Corp Recent Headline News

CVS Health Earns Top Score on 13th Annual Scorecard on LGBT Workplace Equality
PR Newswire - Wed Nov 19, 6:00AM CST
CVS Health announced today that it received a score of 100 percent on the 2015 Corporate Equality Index (CEI), a national benchmarking survey and report on corporate policies and practices related to LGBT workplace equality, administered by the Human Rights Campaign Foundation.
CVS: 90.10 (-0.02)

CVS Health Shares Still Have More Room To Run
Stock Market Sherpa - at Seeking Alpha - Tue Nov 18, 10:45PM CST

CVS: 90.10 (-0.02)

Shutterfly CEO: Holiday Season Is Like the ‘Super Bowl’ for Stock
at The Street - Tue Nov 18, 3:10PM CST
Shutterfly is expecting a strong holiday sales season due to its new product additions including GrooveBook's photo albums, said CEO Jeff Housenbold.
SFLY: 42.10 (-0.13), WMT: 84.52 (+0.73), CVS: 90.10 (-0.02), XRT: 90.40 (+0.03), WAG: 67.68 (-0.38)

Humana Partners with Bill Pay at CVS/pharmacy to Provide Convenient, In-Store Health Insurance Payment Option
Business Wire - Tue Nov 18, 9:00AM CST
Humana Inc. (NYSE: HUM), one of the nation's leading health and well-being companies, and CVS/pharmacy, the retail division of CVS Health (NYSE: CVS), announced today that Humana members with individual, non-Medicare plans purchased from exchanges or humana.com are now able to pay their health insurance premiums in cash, credit or debit via Bill Pay at CVS/pharmacy, a new bill payment platform launched in partnership between CVS/pharmacy and InComm earlier this year. Bill Pay at CVS/pharmacy will help newly-insured people to maintain their health insurance by providing an easy, convenient and fee-free method of paying their monthly insurance bill.
CVS: 90.10 (-0.02), HUM: 137.83 (-1.46)

'Fast Money' Recap: Stay Short the Yen Following Japan's GDP Miss
at The Street - Tue Nov 18, 4:00AM CST
The trading panel discussed Japan's surprising announcement and whether Twitter is a better bet than Facebook or LinkedIn.
CST: 42.51 (+0.09), AMZN: 325.25 (+0.32), GE: 26.81 (-0.20), FB: 73.70 (-0.64), HAL: 48.01 (-0.53), WMT: 84.52 (+0.73), TLT: 119.04 (-0.48), SLB: 94.37 (-0.91), LNKD: 218.55 (-2.52), SUNE: 21.13 (-0.35), TGT: 70.65 (+3.14), CVS: 90.10 (-0.02), GOOGL: 541.57 (-2.94), TWTR: 39.60 (-1.01), GDX: 19.43 (-0.87), BHI: 62.97 (-0.58)

Walgreen Co. - A 5-Star Stock Trading At A Discount, But Is It Enough?
Dividends4Life - at Seeking Alpha - Mon Nov 17, 4:52PM CST

WMT: 84.52 (+0.73), CVS: 90.10 (-0.02), WAG: 67.68 (-0.38), RAD: 5.59 (-0.04)

Post Earnings Update: CVS Caremark Has Climbed 4.3% Higher in Past Week (CVS)
Comtex SmarTrend(R) - Mon Nov 17, 12:16PM CST
A week ago on November 4th, 2014 CVS Caremark (NYSE:CVS) reported earnings and analysts, on average, expected earnings of $1.13 on sales of $34.7 billion. The company actually reported EPS of $1.15 on sales of $35.0 billion, beating EPS estimates by $0.02 and beating revenue estimates by $285.0 million. Shares of CVS Caremark have climbed from $85.47 to $89.13, representing a gain of 4.3% since the company reported earnings 13 days ago.
CVS: 90.10 (-0.02)

Today's Top Performers In Services
at The Street - Mon Nov 17, 11:03AM CST
TheStreet highlights 3 stocks pushing the services sector higher today.
EBAY: 54.39 (-0.99), CVS: 90.10 (-0.02), LOW: 62.19 (+3.66)

How Apple Pay Can Help Mobile Transactions Soar by 2017
at The Street - Mon Nov 17, 9:17AM CST
As digital wallets and mobile payments become more prevalent, transactions on smartphones are expected to soar by 2017.
FB: 73.70 (-0.64), WMT: 84.52 (+0.73), CVS: 90.10 (-0.02), GOOGL: 541.57 (-2.94), AAPL: 114.35 (-1.12)

How Starbucks Could Take On Apple In Mobile Payments
at Investor's Business Daily - Mon Nov 17, 7:02AM CST
Starbucks customers are a loyal bunch -- loyal enough to protest the departure of their beloved eggnog latte, prompting the coffee chain to revive the seasonal favorite, and loyal enough to make the company the No. 1 most-expensed restaurant for...
SBUX: 77.82 (+0.25), EBAY: 54.39 (-0.99), CVS: 90.10 (-0.02), WMT: 84.52 (+0.73), GOOGL: 541.57 (-2.94), AAPL: 114.35 (-1.12), RAD: 5.60 (-0.03)

Dividend Contenders: 26 Increases Expected In The Next 11 Weeks
David Fish - at Seeking Alpha - Mon Nov 17, 6:36AM CST

RGCO: 21.82 (-0.07), ROP: 155.87 (-0.41), SEIC: 38.77 (-0.15), NKE: 96.64 (+0.17), SJI: 56.42 (-0.13), AEL: 26.87 (-0.14), YORW: 20.67 (-0.58), ECL: 113.02 (-0.16), SYK: 90.12 (-0.04), AXS: 49.48 (-0.24), TGP: 38.90 (+0.06), JJSF: 102.75 (-0.26), GGG: 77.91 (-1.16), NWFL: 28.65 (-0.50), CVS: 90.10 (-0.02), UBA: 21.74 (-0.13), ERIE: 84.76 (-0.02), ANDE: 54.69 (+0.21), EIX: 62.22 (-0.48), LG: 50.41 (-0.17), LNT: 62.29 (-0.27), VGR: 21.23 (-0.23)

CVS Caremark Has Returned 14.7% Since SmarTrend Recommendation (CVS)
Comtex SmarTrend(R) - Fri Nov 14, 9:22AM CST
SmarTrend identified an Uptrend for CVS Caremark (NYSE:CVS) on July 24th, 2014 at $78.59. In approximately 4 months, CVS Caremark has returned 14.68% as of today's recent price of $90.12.
CVS: 90.10 (-0.02)

Why Rite Aid Will Retest $9
Brian Nichols - at Seeking Alpha - Thu Nov 13, 3:08PM CST

CVS: 90.10 (-0.02), WAG: 67.68 (-0.38), RAD: 5.60 (-0.03)

CVS Health Introduces Robust Consumer Education Resources for Upcoming Health Insurance Marketplace Open Enrollment
PR Newswire - Thu Nov 13, 10:30AM CST
CVS Health (NYSE: CVS) today announced a robust educational effort to increase its customers' understanding of available insurance options during the upcoming Affordable Care Act (ACA) Health Insurance Marketplace open enrollment period of November 15, 2014 to February 15, 2015. CVS Health is partnering with numerous health insurers offering coverage on the Marketplace to conduct health insurance education events in CVS/pharmacy stores. The outreach campaign will also involve in-store brochure displays and online insurance information and tools at CVS.com/insurance. Additionally, CVS Health is releasing new data that provides an initial look at prescription drug utilization by patients newly insured under the ACA. This data examines the population enrolled and how they are using their health insurance coverage, offering valuable insights for consumers, insurers and other stakeholders as they prepare for this year's open enrollment.
CVS: 90.10 (-0.02)

MinuteClinic Opens Its First Walk-in Medical Clinics in Wisconsin
PR Newswire - Thu Nov 13, 7:00AM CST
The first MinuteClinic walk-in medical clinics have opened in Wisconsin inside four CVS/pharmacy stores in Milwaukee, Menomonee Falls and Waukesha. MinuteClinic, the retail medical clinic of CVS Health, is the largest and fastest growing provider of walk-in clinics in the U.S, with locations in 31 states and the District of Columbia.
CVS: 90.10 (-0.02)

Tracking The Parnassus Core Equity Fund
IVI Guy - at Seeking Alpha - Wed Nov 12, 6:45AM CST

WDFC: 74.97 (-0.83), SJR: 26.99 (-0.07), PRGO: 158.85 (-1.09), XYL: 37.26 (-0.95), CHRW: 72.01 (-0.53), MDLZ: 38.89 (+0.20), MKC: 72.51 (+0.01), MDU: 25.36 (+0.08), SYY: 39.08 (-0.06), PDCO: 46.53 (-0.08), PNR: 67.24 (-1.27), TRI: 37.98 (-0.09), UPS: 105.53 (-0.50), PEP: 98.12 (+0.18), AGN: 213.10 (-0.27), MSI: 65.64 (-0.36), NOV: 71.53 (-0.52), NWN: 46.11 (-0.08), EGN: 65.59 (-0.97), EBAY: 54.40 (-0.98), QCOM: 70.77 (-1.24), AMAT: 22.61 (-0.07), ACN: 83.60 (-0.70), AAPL: 114.37 (-1.10), MA: 83.62 (-0.28), SCHW: 28.34 (-0.42), STR: 23.62 (+0.22), SE: 38.65 (+0.09), GAS: 51.71 (-0.09), IRM: 37.57 (-0.17), WM: 48.45 (-0.65), CMP: 90.60 (-0.16), VRSK: 62.35 (-0.34), GILD: 101.69 (-2.02), EXPD: 43.63 (-0.29), TFX: 115.16 (+0.01), CVS: 90.10 (-0.02), PG: 88.33 (+0.38), PX: 127.76 (-0.07), NVS: 95.28 (-0.30)

A Check-Up On The Earnings Of CVS Health
David Schauber, Jr. - at Seeking Alpha - Wed Nov 12, 4:08AM CST

CVS: 90.10 (-0.02)

Next Resistance Level for CVS Caremark (CVS) is $90.06
Comtex SmarTrend(R) - Tue Nov 11, 9:34AM CST
CVS Caremark (NYSE:CVS) has opened bullishly above the pivot of $88.77 today and has reached the first level of resistance at $89.63. Investors may be interested in a cross of the next upside pivot targets of $90.06 and $91.35.
CVS: 90.10 (-0.02)

3 Stocks Raising The Services Sector Higher
at The Street - Mon Nov 10, 11:08AM CST
TheStreet highlights 3 stocks pushing the health care sector higher today.
CVS: 90.10 (-0.02), WAG: 67.68 (-0.38), UNP: 119.93 (-0.69)

Hess Corporation Tops Best Value Long-Term Bond Ranking
Donald van Deventer - at Seeking Alpha - Sun Nov 09, 8:58AM CST

PSX: 74.01 (+0.05), SCCO: 29.80 (-0.52), SWY: 34.86 (+0.08), HES: 81.84 (-0.06), UTX: 108.55 (-0.25), RTN: 104.07 (-0.06), WMT: 84.52 (+0.73), TAP: 74.87 (-1.46), AMGN: 161.78 (-0.46), COP: 71.55 (-0.12), SWK: 94.61 (-0.51), DO: 34.89 (-0.42), IBM: 161.42 (-0.47), CVS: 90.10 (-0.02), CAT: 101.34 (-0.70), PPG: 209.24 (+0.74), WAG: 67.68 (-0.38)

CVS Health Corp. (CVS) Stock Research Links

CVS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AST SpaceMobile Faces Investor Turbulence Amid Concerns

Updated Category News Views 2

AST SpaceMobile's Unsteady Ground Let's dig into the wild ride AST SpaceMobile (NASDAQ: ASTS) has found itself on. These folks have been taking punches from every direction, from Wall Street's bean counters to hostile market winds. It all started when Scotiabank slapped them with a 'Sell' rating on January 6, 2026, pointing fingers at their faltering position against...

Continue Reading
PrecisePK Celebrates 40 Years of Revolution in Dosing

Updated Category News Views 2

Forty Years of Changing the Game There’s something to be said for sticking around in an industry for four decades. PrecisePK, a name that's become synonymous with precision dosing, has been revolutionizing how pharmacists do their jobs since 1985. This isn’t just a company resting on its laurels; it’s at the forefront of technological integration in healthcare....

Continue Reading
Teleste Unveils AI-Enhanced Rail Info Platform Innovation

Updated Category News Views 0

A Shake-Up in Rail Passenger Information Now, here's something from left field that might just have people paying attention while on the go. Teleste, a Finnish company, just put out a gem in rail passenger information systems with the introduction of Acapela's AI-based voice tech into their S-ARRIVE platform. Picture clearer, more natural announcements for every stop,...

Continue Reading
Nevada Organic Phosphate Strikes Gold With Murdock Drills

Updated Category News Views 0

Mineralization in Murdock Mountain: Stakeholders Keep an Eye Well, here we are—another notch in the belt for Nevada Organic Phosphate Inc. They're rattling off good news from deep within the belly of Murdock Mountain. Drill hole MM26-12 has intersected a hearty 37.4 meters of the target Meade Peak Member, and the expectations are climbing faster than a rodeo bull. With...

Continue Reading
Parents as Teachers Podcast: Anthem Awards Finalist

Updated Category News Views 7

Celebrating Impact Through Parenthood Narratives Blending heartfelt stories with educational insights, the Parents as Teachers Podcast stands tall as a Finalist in two categories of the 6th Annual Anthem Awards. Recognizing achievements in Content & Media for both Education, Art & Culture and Health, this nod acknowledges the profound impact being made on family...

Continue Reading
Baidu Faces Class Action Over Misleading AI Revenue Claims

Updated Category News Views 6

Another Day, Another Lawsuit Nothing says 'start your week' quite like the sounds of courtroom battles echoing across the market landscape. Baidu, Inc. (NASDAQ: BIDU) finds itself in the legal crosshairs, courtesy of the DJS Law Group. They're being accused of some shady dealings, and the core of this drama is all about what they claimed versus the reality of their...

Continue Reading
BMO's Bold Leadership Shuffle: Cox Takes Helm

Updated Category News Views 9

Fresh Blood at the Helm: Tim Cox's New Role BMO's leadership is getting a shakeup worthy of any Wall Street drama. Tim Cox, a name insiders hail for his sharp legal mind and strategic chops, is stepping up as the U.S. Country Head for BMO. Come November 1st, he'll be steering BMO's massive U.S. subsidiaries like BMO Financial Corp. and BMO Bank N.A. It's a big leap from...

Continue Reading
M&T Bank Declares Quarterly Preferred Dividends

Updated Category News Views 4

No Surprises Here—M&T Pays Out Big On Preferreds If there's one thing the market just loves to see amid all this noise and chatter, it's cash coming back to shareholders. M&T Bank Corporation, a seasoned player in the financial sector, is keeping its shareholders happy with some neat quarterly preferred stock dividends. Now, if you've been poking around the NYSE:MTB...

Continue Reading
Knexus Teams with Google Cloud to Boost Public Sector AI

Updated Category News Views 9

Kicking Off a New Era for AI in Government There's a fresh wind blowing in how government agencies approach artificial intelligence, and it’s got Knexus and Google Cloud’s Gemini initiative written all over it. Set in Vienna, Virginia, the announcement rolls out a heavy-hitting collaboration that might just rewire how public sectors handle data. October 20, 2026,...

Continue Reading
Meitav Tops 2025 Service Index with Stellar Growth

Updated Category News Views 5

Meitav’s Leap to The Summit Damn, it's a wild market when a pension fund provider snatches the crown. But here we are, looking at Meitav Provident Funds and Pension Ltd., standing proudly as Israel's top dog in the 2025 Service Index for pension funds. We're talking a jump from fourth to numero uno, folks, with a hefty score of 83 out of 100. And don't sleep on their...

Continue Reading

Top 5 Most Recently Viewed Articles

Pfizer and Eli Lilly: Discovering Value in Pharma Stocks

Updated Category News Views 137

Valuations in the biopharma sector hit wild swings, dragging investors to hunt for bargains. Back in the day, Pfizer was riding high on booming revenues, but that turned into a horror show as its trailing twelve-month operating income dropped to $1.3 billion—a staggering 94% plunge over three years. The culprit? A nosedive in sales from COVID-19 products and...

Continue Reading
Graco Inc. Announces Substantial Quarterly Dividend Boost

Updated Category News Views 133

Graco Inc. Increases Dividend for Shareholders Graco Inc. has made a significant announcement regarding its quarterly dividend policies that enthusiastic investors should take note of. Recently, the Board of Directors declared a quarterly dividend increase of 7.8 percent, bringing the total to 27.5 cents (or $0.275) per common share. This marks a major move for the...

Continue Reading
ParaZero's Revolutionary Airdrop System Gains Global Approval

Updated Category News Views 155

ParaZero Secures Global Marketing Approval for DropAir System ParaZero Technologies Ltd. (Nasdaq: PRZO) is on an exciting path of growth as it emphatically strides into new markets. The company, based in Israel, has recently announced that it has received official marketing approval from the Israeli Ministry of Defense for its innovative DropAir Precision Airdrop System....

Continue Reading
Nautilus Biotechnology Prepares for Third Quarter 2025 Results

Updated Category News Views 138

Nautilus Biotechnology Plans Q3 2025 Financial Results Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a pioneering company focused on single-molecule protein analysis, is set to announce its third quarter financial results. This report is scheduled for release before market opening on Tuesday. Webcast Conference Call to Discuss Financial Results The management team of...

Continue Reading
Bluebird Bio's Acquisition: What Investors Need to Know

Updated Category News Views 166

Understanding Bluebird Bio's Recent Acquisition Bluebird Bio, Inc. BLUE has recently made headlines after entering into a definitive agreement to be acquired by prominent global investment firms Carlyle Group Inc. CG and SK Capital Partners. This development is pivotal for Bluebird, a company focused on gene therapy, which seeks to address rare genetic diseases. Financi

Continue Reading